These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. da Costa DE, Pai MG, Al Khusaiby SM. Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709 [Abstract] [Full Text] [Related]
9. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta. Lloyd J, Todd DA, John E. Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294 [Abstract] [Full Text] [Related]
13. Controversies: synthetic or natural surfactant. The case for natural surfactant. Halliday HL. J Perinat Med; 1996 Mar; 24(5):417-26. PubMed ID: 8950721 [Abstract] [Full Text] [Related]
14. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. Sehgal SS, Ewing CK, Richards T, Taeusch HW. J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722 [Abstract] [Full Text] [Related]
17. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. Dechant KL, Faulds D. Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378 [Abstract] [Full Text] [Related]
18. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity. Modanlou HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV. J Perinatol; 1997 Nov; 17(6):455-60. PubMed ID: 9447532 [Abstract] [Full Text] [Related]